This research advanced quickly, and by there were several studies being conducted that compared the effects of different synthetic hormones being delivered through six contraceptive rods. In , a randomized control trial taking place in six countries determined that the implants containing levonorgestrel were the best option in terms of safety and efficacy. In , the Finnish pharmaceutical company Leiras Oy was licensed to produce the six-rod contraceptive system, known as Norplant, and by the The World Health Organization WHO evaluated and recommended the system worldwide to regulate fertility.
Soon after its approval in Finland, it became available in several other countries throughout the world, and was finally approved by the FDA in Since , the Population Council estimates that While Norplant and Jadelle are still available outside the US, neither are available here.
Ethics and law. Medical education. Medicine and the law. Volume Issue 2. Implanon and medical indemnity: a case study of risk management using the Australian Standard. Med J Aust ; 2 : Topics Women's health. Abstract The contraceptive implant Implanon Organon was introduced in Australia in May , and in the next 18 months was associated with an unprecedented number of adverse incident reports to medical indemnity insurers, including almost unintended pregnancies.
Background Implanon is a progestogen-only implant that acts as a long-term 3-year contraceptive. Incident notifications Medical practitioners are required by their medical indemnity insurers to report any incident or adverse outcome that may give rise to a claim. Initial consultation The practitioner is required to: Check for contraindications and allergies; Plan the date of insertion; and Disclose the risks.
The patient is required to: Palpate the implant after insertion; and Complete the consent form, acknowleging understanding of the treatment and that the implant is palpable. Removal The practitioner is required to: Document removal on the checklist and enter this in the medical record.
View this article on Wiley Online Library. Competing interests:. Standards Australia, Foran TM. New contraceptive choices across reproductive life, Med J Aust ; Cherry S. Implanon, the new alternative. Aust Fam Physician ; Implanon Product information.
Oss, Netherlands: NV Organon, Munro J, Moss R. Implanon is effective but beware risks. Law in practice. Aust Doctor ; 10 May: Gerber P. Failed sterilisations and the unwanted child: a new medicolegal minefield? Med J Aust ; Maddern GJ. RACS Bull ; Standards for general practice. First Name. Middle Name. Although on-site provision of the implant has increased in both Title X and non-Title X clinics in recent years, Title X clinics are more likely than non-Title X clinics to offer implants on-site.
Recent initiatives around the country have found young women are very likely to choose the most effective methods of contraception when cost barriers are removed and contraceptive counseling is provided. Louis, MO, region contraception of their choice with no cost sharing, leading to a reduction in teen births and repeat abortions among participants.
Research shows that satisfaction and continuation rates were relatively high among women who chose either method [Table 1]. High continuation rates among implant users have also been documented in populations with Medicaid coverage and coverage through an employer.
Contraceptive implants are the most effective form of contraception, but use is relatively low, owing in part to: lack of awareness they are newer to the market than many other methods ; misperceptions about safety and efficacy; and high up-front costs. However, recent guidelines and initiatives have promoted implants and other long-acting reversible contraceptives as a first-line of defense against unintended pregnancy and an increasing share of health centers are offering them.
Programs that eliminate the high up-front financial barriers combined with contraceptive counseling may lead to increased use of highly-effective methods like the implant and contribute to a reduction in unintended pregnancies. McNicholas, C, et al.
Use of the etonogestrel implant and levonorgestrel intrauterine device beyond the U. Food and Drug Administration—approved duration. Obstetrics and Gynecology 3. Ali, M, et al. Extended use up to 5 years of the etonogestrel-releasing subdermal contraceptive implant: comparison to levonorgestrel-releasing subdermal implant.
Human Reproduction 31 Phillips S, et al. Progestogen-only contraceptive use among breastfeeding women: a systematic review. Contraception 94 3. Diedrich, J, et al. Three-year continuation of reversible contraception. American Journal of Obstetrics and Gynecology 5. Luchowski, A, et al.
Obstetrician-Gynecologists and contraception: long-acting reversible contraception practices and education. Contraception 89 6. Thompson, et al. American Journal of Obstetrics and Gynecology 6. Morgan, et al. Journal of Pediatric and Adolescent Gynecology 32 4. Davis, S, et al. This finding is similar with study conducted in Tigray in Northern Ethiopia [ 13 ]. This might be those who choose the methods by themselves have information about the method and expected side effects.
This finding also in line with studies done in low income countries [ 26 ]. This might be during follow up visit, if any compliant coming from the client, they will get appropriate solution from the health workers and also there might be post insertion counseling on the expected side effects specific to Implanon.
This finding is also similar to studies done in Tigray in Northern Ethiopia and Louis City [ 9 , 13 , 25 ]. This study finding might not be used to generalize for women in urban places and recall bias can be introduced according to date of insertion and removal of Implanon. Implanon discontinuation rate in this study was substantially high and the main factors for discontinuation were lack of pre insertion counseling, lack of satisfaction due to poor service delivery and lack of appointment for follow up.
Thus, proper pre-insertion counseling and follow up will improve the continuation rate of Implanon. Ovarian function during the use of a single contraceptive implant: Implanon compared with Norplant.
Fertil Steril. Contraceptive implants. Afr J Repod Health. Article Google Scholar. Renewing focus on family planning service quality globally. Contraception and Reproductive Medicine. Prevalence and predictors of Implanon utilization among women of reproductive age group in Tigray region, northern Ethiopia. Reprod Health. Cadernos de saude publica. Importance of appropriate counselling in reducing early discontinuation of Norplant in a northern district of Bangladesh.
J Health Popul Nutr. Ethiopia Demographic and Health Survey. Google Scholar. Early discontinuation of Implanon and its associated factors among women who ever used Implanon in Ofla District, Tigray. Northern Ethiopia. Determinant of Implanon discontinuation among women who ever used Implanon in Diguna Fango District, Wolayita zone, southern Ethiopia: a community based case control study.
International Journal of Reproductive Medicine. Early Implanon discontinuation and associated factors among Implanon user women in Debre Tabor town, public health facilities, Northwest Ethiopia, Tseganeh W. Assessment of quality of family planning service.
Early discontinuation of Implanon and its associated factors among women who ever used Implanon in Ofla District, Tigray, Northern Ethiopia. Mutihir J, Nyango D. One-year experience with Implanon sub-dermal implants in Jos, Nigeria Nigerian. Journal of Clinical Practice. Implanon: subdermal single rod contraceptive implant. The Journal of Obstetrics and Gynecology of India. Uptake of hormonal implants contraceptive in Zaria, northern Nigeria.
Open Journal of Obstetrics and Gynecology. A randomized clinical trial of the effect of intensive versus non-intensive counselling on discontinuation rates due to bleeding disturbances of three long-acting reversible contraceptives. Hum Reprod. Agrawal A, Robinson C. Burusie A. Reasons for premature removal of Implanon among users in Arsi zone, Oromia region, Ethiopia, Reprod Syst Sex Disord.
DaruPH factors associated with use and discontinuation of Implanon contraceptive in Jos. Nigeria Tropical Journal of Obstetrics and Gynaecology. Jacobstein R, Stanley H. Contraceptive implants: providing better choice to meet growing family planning demand.
Glob Health Sci Pract. Characteristics associated with discontinuation of long-acting reversible contraception within the first 6 months of use. Obstet Gynecol. Determinants of early implant discontinuation among low-income women.
Perspect Sex Reprod Health.
0コメント